On March 15, 2022 Philogen reported that it is presenting a ePoster entitled "A novel tumor-targeting cytokine-based therapy in combination with lomustine displays promising anti-tumor activity against glioblastoma" (Presentation, Philogen, MAR 15, 2022, View Source [SID1234610107]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!